181 related articles for article (PubMed ID: 26967972)
1. Pitavastatin and carbohydrate metabolism: what is the evidence?
Filippatos TD; Elisaf MS
Expert Rev Clin Pharmacol; 2016 Jul; 9(7):955-60. PubMed ID: 26967972
[TBL] [Abstract][Full Text] [Related]
2. Are all statins the same? Focus on the efficacy and tolerability of pitavastatin.
da Silva PM
Am J Cardiovasc Drugs; 2011; 11(2):93-107. PubMed ID: 21446776
[TBL] [Abstract][Full Text] [Related]
3. Clinical benefits of pitavastatin: focus on patients with diabetes or at risk of developing diabetes.
Barrios V; Escobar C
Future Cardiol; 2016 Jul; 12(4):449-66. PubMed ID: 27076402
[TBL] [Abstract][Full Text] [Related]
4. Pitavastatin: novel effects on lipid parameters.
Chapman MJ
Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
[TBL] [Abstract][Full Text] [Related]
5. Pitavastatin: an overview.
Saito Y
Atheroscler Suppl; 2011 Nov; 12(3):271-6. PubMed ID: 22152281
[TBL] [Abstract][Full Text] [Related]
6. Effects of pitavastatin on adiponectin in patients with hyperlipidemia.
Inami N; Nomura S; Shouzu A; Omoto S; Kimura Y; Takahashi N; Tanaka A; Nanba M; Shouda Y; Iwasaka T
Pathophysiol Haemost Thromb; 2007; 36(1):1-8. PubMed ID: 18332608
[TBL] [Abstract][Full Text] [Related]
7. Searching the place of pitavastatin in the current treatment of patients with dyslipidemia.
Barrios V; Escobar C; Zamorano JL
Expert Rev Cardiovasc Ther; 2013 Dec; 11(12):1597-612. PubMed ID: 24215190
[TBL] [Abstract][Full Text] [Related]
8. Could changes in adiponectin drive the effect of statins on the risk of new-onset diabetes? The case of pitavastatin.
Arnaboldi L; Corsini A
Atheroscler Suppl; 2015 Jan; 16():1-27. PubMed ID: 25575403
[TBL] [Abstract][Full Text] [Related]
9. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
10. Place of pitavastatin in the statin armamentarium: promising evidence for a role in diabetes mellitus.
Kawai Y; Sato-Ishida R; Motoyama A; Kajinami K
Drug Des Devel Ther; 2011; 5():283-97. PubMed ID: 21625418
[TBL] [Abstract][Full Text] [Related]
11. Pitavastatin calcium: clinical review of a new antihyperlipidemic medication.
Yee LL; Wright EA
Clin Ther; 2011 Aug; 33(8):1023-42. PubMed ID: 21816477
[TBL] [Abstract][Full Text] [Related]
12. Pitavastatin in cardiometabolic disease: therapeutic profile.
Masana L
Cardiovasc Diabetol; 2013; 12 Suppl 1(Suppl 1):S2. PubMed ID: 23819752
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of pitavastatin for the treatment of hypercholesterolemia.
Chan P; Shao L; Tomlinson B; Zhang Y; Liu ZM
Expert Opin Pharmacother; 2019 Jan; 20(1):103-113. PubMed ID: 30482061
[TBL] [Abstract][Full Text] [Related]
14. Impact of pitavastatin on high-sensitivity C-reactive protein and adiponectin in hypercholesterolemic patients with the metabolic syndrome: the PREMIUM Study.
Matsubara T; Naruse K; Arakawa T; Nakao M; Yokoi K; Oguri M; Marui N; Amano T; Ichimiya S; Ohashi T; Imai K; Sakai S; Sugiyama S; Ishii H; Murohara T
J Cardiol; 2012 Nov; 60(5):389-94. PubMed ID: 22884685
[TBL] [Abstract][Full Text] [Related]
15. The clinical impact of pitavastatin: comparative studies with other statins on LDL-C and HDL-C.
Teramoto T
Expert Opin Pharmacother; 2012 Apr; 13(6):859-65. PubMed ID: 22332608
[TBL] [Abstract][Full Text] [Related]
16. Comparison of pitavastatin with atorvastatin in increasing HDL-cholesterol and adiponectin in patients with dyslipidemia and coronary artery disease: the COMPACT-CAD study.
Kurogi K; Sugiyama S; Sakamoto K; Tayama S; Nakamura S; Biwa T; Matsui K; Ogawa H;
J Cardiol; 2013 Aug; 62(2):87-94. PubMed ID: 23672789
[TBL] [Abstract][Full Text] [Related]
17. New evidence on pitavastatin: efficacy and safety in clinical studies.
Teramoto T; Shimano H; Yokote K; Urashima M
Expert Opin Pharmacother; 2010 Apr; 11(5):817-28. PubMed ID: 20201733
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia.
Lee SH; Chung N; Kwan J; Kim DI; Kim WH; Kim CJ; Kim HS; Park SH; Seo HS; Shin DG; Shin YW; Shim WJ; Ahn TH; Ho Yun K; Yoon MH; Cha KS; Choi SW; Han SW; Hyon MS
Clin Ther; 2007 Nov; 29(11):2365-73. PubMed ID: 18158077
[TBL] [Abstract][Full Text] [Related]
19. The effects of pitavastatin, eicosapentaenoic acid and combined therapy on platelet-derived microparticles and adiponectin in hyperlipidemic, diabetic patients.
Nomura S; Inami N; Shouzu A; Omoto S; Kimura Y; Takahashi N; Tanaka A; Urase F; Maeda Y; Ohtani H; Iwasaka T
Platelets; 2009 Feb; 20(1):16-22. PubMed ID: 19172517
[TBL] [Abstract][Full Text] [Related]
20. Pitavastatin and HDL: Effects on plasma levels and function(s).
Pirillo A; Catapano AL
Atheroscler Suppl; 2017 Jul; 27():e1-e9. PubMed ID: 28716185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]